Searched for
PRASHANT KISHOR INCOME
Nitish Kumar's new cabinet full of corrupts, criminals, alleges Prashant KishorPrashant Kishor criticizes Nitish Kumar's new Bihar cabinet, calling it corrupt. He announces the 'Bihar Navnirman Sankalp Yatra' starting ...- Why the NDA is keeping quiet on Bihar’s liquor banAs Bihar gears up for elections, prohibition, once a hallmark of Nitish Kumar's governance, has become a silent burden for the ruling NDA. ...
- Bihar deputy CM lied before SC to escape murder trial, alleges Prashant KishorPrashant Kishor alleged Bihar Deputy CM Samrat Choudhary escaped a 1995 mass murder trial by falsely claiming minority status to the Suprem...
- Buy Ipca Laboratories, target price Rs 1,980: Motilal Oswal Financial ServicesMotilal Oswal Financial Services recommends buying Ipca Laboratories with a target price of Rs 1980. The company reported strong quarterly ...
- Bihar a failed state: Prashant Kishor tells Bihari diaspora in USDuring a virtual interaction with the Bihari diaspora community, Jan Suraaj leader Prashant Kishor characterized Bihar as a "failed state" ...
- Rs 100 crore fee? Prashant Kishor reveals his unheard of election advice feesPrashant Kishor, chief of Jan Suraaj Party, revealed he charges over one hundred crore for election advice. This funds his political campai...
- Hold Ipca Laboratories, target price Rs 790: Sharekhan by BNP ParibasIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 17596.92 Crore) operating in Pharmaceutic...
- Buy Ipca Laboratories, target price Rs 940: Motilal Oswal Financial ServicesIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 18871.79 Crore) operating in Pharmaceutic...
- Buy Ipca Laboratories, target price Rs 940: ICICI DirectIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 20933.14 Crore) operating in Pharmaceutic...
- Buy Ipca Laboratories, target price Rs 1115: JM FinancialJM Financial adjusts its earnings by 3-5% to factor a gradual GM improvement.
- Hold Ipca Laboratories, target price Rs 909: Sharekhan by BNP ParibasIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 20944.55 Crore) operating in Pharmaceutic...
- Add Ipca Laboratories, target price Rs 893: Choice Equity BrokingChoice Broking values the stock based on Sep-24E EPS to arrive at a target price of Rs 893 (valuing at 25x) and improve its rating from neu...
- Buy Ipca Laboratories, target price Rs 1010: JM FinancialIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 20911.57 Crore) operating in Pharmaceutic...
- Hold Ipca Laboratories, target price Rs 865: Prabhudas LilladherAt CMP, the stock is trading at 23x FY25E factoring in near term recovery.
- Buy Ipca Laboratories, target price Rs 1000: Motilal Oswal Financial ServicesPromoters held 46.29 per cent stake in the company as of 30-Sep-2022, while FIIs owned 10.61 per cent, DIIs 33.46 per cent.
- Prashant Kishor working on behalf of BJP: JD(U)JD(U) president Rajiv Ranjan Singh alias Lalan also berated Kishor's statewide "pada yatra" and fulminated against his refrain that Bihar r...
- Accumulate Ipca Laboratories, target price Rs 1000: Prabhudas LilladherFor the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1607.85 crore, up 23.34 per cent from last ...
- Mamata Banerjee terms Pegasus spy scandal as worse than Watergate, exhorts people to protestThe West Bengal chief minister exhorted civil society, students, media-persons to rise in protest against the misuse of the spyware.
- Youth Congress plans jobs, allowance for unemployedTaking cue from UP’s Kisan Maangpatra, the party will roll out a form for employment.
- Tax notice sent to CAG that ran Narendra Modi's 2014 elections campaign; service tax obligations of co under lensThe entity has been asked to produce annual reports, bills, invoices, expenditure ledgers, bank statement with payment receipts among other...
Load More
